Clinical Trial

A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the effect of AZD5004 on the pharmacokinetics (PK) of mitiglinide and pioglitazone in healthy participants.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-14
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-23
critical Recruitment opened 2026-03-31
Trial Details
NCT Number NCT07444424
Lead Sponsor AstraZeneca
Collaborators: Parexel
Conditions Healthy Participants
Enrollment 32 participants
Start Date 2026-03-13
Primary Completion 2026-07-02 (estimated)
Study Completion 2026-07-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-13